RxDoctor Payments Data

Harold Tabaie, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Los Angeles, CANPI 1346286663

Payments from drug & device makers

What this record shows

This record is dominated by other: $105,347 of the $119,626 with a category attached, or 88.1%. Merit Medical Systems Inc accounts for 88.1% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2024 at $106,984 and has fallen 99.1% since, to $922 in 2025. Among thoracic surgery (cardiothoracic vascular surgery) clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$119,626in general payments, 2019–2025

Across 271 payments — averaging $441.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merit Medical Systems Inc$105K
  • Cook Medical LLC$6K
  • Terumo Medical Corporation$3K
  • Cardiovascular Systems Inc.$2K
  • Bard Peripheral Vascular, Inc.$979
  • BD$772
  • plus $2K from 12 others

What the payments were for

  • Travel & lodging$3,2783%
  • Food & beverage$11,0029%
  • Other$105,34788%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$119,626 in reported general payments places this provider in the 90th percentile of 546 thoracic surgery (cardiothoracic vascular surgery) providers in California.

See all thoracic surgery (cardiothoracic vascular surgery) providers in California

Medicare billing

Part B allowed, 2024
$6,890,205
Medicare patients
146
Services billed
4,283

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban25$22,587
Diclofenac Sodium12$2,345
ClopidogrelClopidogrel Bisulfate203$1,963
CefuroximeCefuroxime Axetil17$213
Tramadol Hcl172$118
Alprazolam105$37

Paid to pharmacies, not to this prescriber.

Other thoracic surgery (cardiothoracic vascular surgery) in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →